These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1312854)

  • 21. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.
    Langtry HD; Markham A
    Drugs Aging; 1997 Feb; 10(2):131-66. PubMed ID: 9061270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension.
    Pontremoli R; Viazzi F; Ravera M; Leoncini G; Berruti V; Bezante GP; Del Sette M; Deferrari G
    J Nephrol; 2001; 14(1):19-26. PubMed ID: 11281339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
    Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC
    Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
    Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
    Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC; Plevris JN; Bouchier IA
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of lisinopril and nifedipine on parotid function: two case reports.
    Streckfus CF; Welsh S; Jenkins P; Brown R; Miller V
    MSDA J; 1992; 35(4):11-4. PubMed ID: 9552628
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of lisinopril on platelet aggregation in patients with arterial hypertension with metabolic syndrome].
    Medvedev IN; Gromnatskiĭ NI; Golikov BM; Al'-Zuraĭki EM; Li VIu
    Kardiologiia; 2004; 44(10):57-9. PubMed ID: 15477792
    [No Abstract]   [Full Text] [Related]  

  • 32. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG; Kramer HJ
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical pharmacology of lisinopril.
    Case DE
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension].
    Alekseenko SA; Timoshin SS; Avilova AA; Fleĭshman MIu; Lamekhova VG
    Klin Med (Mosk); 2004; 82(9):42-5. PubMed ID: 15540422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjects.
    Erne P; Resink TJ; Bolli P; Hefti A; Ritz R; Bühler FR
    J Hypertens Suppl; 1984 Dec; 2(3):S159-61. PubMed ID: 6400364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE-inhibition, kinins, and vascular PGI2 synthesis.
    Hoffmann G; Düsing R
    Eicosanoids; 1992; 5 Suppl():S60-2. PubMed ID: 1333254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA; Murray KM
    Clin Pharm; 1988 Sep; 7(9):659-69. PubMed ID: 2853660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.